US · SONM · COMMUNICATION EQUIPMENT
DNA X, Inc. (SONM) intrinsic value and stock valuation
$1.51as of 2026-11-21 · Mkt cap 5.94M
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
DNA X, Inc. DCF and intrinsic value
InvestorsCraft values SONM with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from SONM’s statements →
DNA X, Inc. Graham Number
The Graham Number is not defined for negative earnings or book value. Guide · Calculator →
How the business is doing
Fiscal 2017–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- Energous Corporation (WATT) $6.32
- MMTec, Inc. (MTC) $5.23
- FiEE, Inc. (FIEE) $2.72
- Nvni Group Limited Ordinary Shares (NVNI) $0.53
- ClearOne, Inc. (CLRO) $4.34
- Gaxos.ai Inc. (GXAI) $0.36
- SOS Limited (SOS) $4.06
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.00 | $58.3M | $93.6M | $69.8M | $54.6M |
| Operating income | -$-5.41M | -$-33.64M | $510K | -$-14.29M | -$-38M |
| Net income | -$-20.66M | -$-33.65M | -$-90K | -$-14.09M | -$-38.63M |
| EPSd | -$-1.59M | -$-7.13M | -$-20.98K | -$-4.88M | -$-40.66M |
| Operating cash flow | -$-23.53M | -$-8.49M | -$-4.05M | -$-12.36M | -$-38.48M |
| Capital expenditure | $0.00 | -$-210K | -$-40K | -$-10K | -$-50K |
| Free cash flow | -$-23.53M | -$-8.7M | -$-4.09M | -$-12.37M | -$-38.52M |
| Total assets | $43.9M | $39.7M | $56M | $53.7M | $41.1M |
| Total debt | $5.07M | $0.00 | $60K | $210K | $210K |
| Net debt | $3.76M | -$-5.34M | -$-9.34M | -$-13M | -$-11.02M |
| Total equity | -$-6.73M | -$-5.7M | $22.4M | $20.1M | $18.6M |
| Cash and short-term investments | $1.3M | $5.34M | $9.4M | $13.2M | $11.2M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.00 | $58.3M | $93.6M | $69.8M | $54.6M |
| Cost of revenue | $4.3M | $48.4M | $74.3M | $58.2M | $48.2M |
| Gross profit | -$-4.3M | $9.92M | $19.3M | $11.6M | $6.41M |
| Research and development expenses | $0.00 | $14.2M | $1.77M | $7.97M | $17.7M |
| Selling, general and administrative expenses | $5.41M | $25.4M | $17M | $17.9M | $26.7M |
| Other expenses | -$-4.3M | $3.98M | $0.00 | $0.00 | $0.00 |
| Operating expenses | $1.11M | $43.6M | $18.8M | $25.9M | $44.4M |
| Cost and expenses | $5.41M | $91.9M | $93.1M | $84.1M | $92.6M |
| Interest income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest expense | $1.49M | $30K | $10K | $100K | $0.00 |
| Depreciation and amortization | $4.3M | $3.56M | $2.21M | $2.38M | $2.13M |
| Ebitda | -$-2.17M | -$-29.84M | $2.5M | -$-11.43M | -$-36.33M |
| Operating income | -$-5.41M | -$-33.64M | $510K | -$-14.29M | -$-38M |
| Total other income/expenses, net | -$-2.55M | $220K | -$-230K | $390K | -$-460K |
| Income before tax | -$-7.96M | -$-33.42M | $280K | -$-13.9M | -$-38.46M |
| Income tax expense | $0.00 | $230K | $370K | $180K | $170K |
| Net income | -$-20.66M | -$-33.65M | -$-90K | -$-14.09M | -$-38.63M |
| Weighted average shares outstanding | $720K | $4.72M | $4.29M | $2.89M | $950K |
| Weighted average diluted shares outstanding | $13M | $4.72M | $4.29M | $2.89M | $950K |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.3M | $5.34M | $9.4M | $13.2M | $11.2M |
| Net receivables | $0.00 | $11.6M | $26.3M | $24.8M | $14.8M |
| Inventory | $0.00 | $10.6M | $6.52M | $3.91M | $5.54M |
| Total current assets | $28.9M | $32.2M | $43.8M | $43.6M | $35.7M |
| Property, plant and equipment, net | $0.00 | $230K | $130K | $230K | $530K |
| Goodwill and intangible assets | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Long-term investments | $1.24M | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current assets | $15M | $7.57M | $12.3M | $10.1M | $5.4M |
| Total assets | $43.9M | $39.7M | $56M | $53.7M | $41.1M |
| Accounts payable | $4.03M | $22.9M | $19.9M | $22.1M | $9.47M |
| Short-term debt | $5.07M | $0.00 | $60K | $210K | $150K |
| Deferred revenue | $0.00 | $0.00 | $10K | $30K | $10K |
| Total current liabilities | $48M | $43.7M | $32.2M | $32.1M | $21M |
| Long-term debt | $0.00 | $0.00 | $0.00 | $0.00 | $70K |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $2.6M | $1.7M | $1.53M | $1.58M | $1.48M |
| Capital lease obligations | $0.00 | $0.00 | $60K | $70K | $0.00 |
| Total liabilities | $50.6M | $45.4M | $33.7M | $33.6M | $22.5M |
| Common stock | $1.23M | $10K | $40K | $40K | $20K |
| Retained earnings | -$-304.26M | -$-283.61M | -$-249.96M | -$-249.87M | -$-234.81M |
| Accumulated other comprehensive income (loss) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total equity | -$-6.73M | -$-5.7M | $22.4M | $20.1M | $18.6M |
| Total investments | $1.24M | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $5.07M | $0.00 | $60K | $210K | $210K |
| Net debt | $3.76M | -$-5.34M | -$-9.34M | -$-13M | -$-11.02M |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | -$-20.66M | -$-33.65M | -$-90K | -$-14.09M | -$-38.63M |
| Depreciation and amortization | $4.3M | $3.54M | $2.21M | $2.38M | $2.13M |
| Stock-based compensation | $1.54M | $1.52M | $1.5M | $1.55M | $1.08M |
| Change in working capital | -$-5.09M | $10.3M | -$-8.31M | -$-1.33M | -$-5.3M |
| Accounts receivable | -$-19.5M | -$-6.11M | -$-1.72M | -$-11.63M | -$-7.52M |
| Inventory | $3.85M | -$-4.99M | -$-2.61M | $1.63M | $4.18M |
| Accounts payable | $9.53M | $14.3M | -$-1.28M | $11.7M | $620K |
| Net cash provided by operating activities | -$-23.53M | -$-8.49M | -$-4.05M | -$-12.36M | -$-38.48M |
| Investments in property, plant and equipment | $0.00 | -$-210K | -$-40K | -$-10K | -$-50K |
| Acquisitions, net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for investing activities | $0.00 | -$-210K | -$-40K | -$-10K | -$-50K |
| Common stock issued | $13.7M | $4.01M | $420K | $14.4M | $27.7M |
| Common stock repurchased | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for financing activities | $19.5M | $4.65M | $270K | $14.4M | $27.6M |
| Net change in cash | -$-4.04M | -$-4.05M | -$-3.82M | $1.98M | -$-10.91M |
| Cash at end of period | $1.3M | $5.34M | $9.4M | $13.2M | $11.2M |
| Operating cash flow | -$-23.53M | -$-8.49M | -$-4.05M | -$-12.36M | -$-38.48M |
| Capital expenditure | $0.00 | -$-210K | -$-40K | -$-10K | -$-50K |
| Free cash flow | -$-23.53M | -$-8.7M | -$-4.09M | -$-12.37M | -$-38.52M |
Line items
Line items
Line items
About DNA X, Inc.
DNA X, Inc., formerly known as Sonim Technologies, Inc. until its rebranding in January 2026, is a company established in 1999 and headquartered in San Diego, California. The firm specializes in delivering enterprise-grade 5G solutions across a broad international footprint, encompassing the United States, Canada, Europe, the Middle East, and the Asia-Pacific region. Their product portfolio includes a comprehensive range of ruggedized communication devices tailored for frontline and task workers. This lineup features models such as the Sonim XP10, Sonim XP5plus, Sonim XP3plus, Sonim XP Pro, as well as the XP100 4G and XP400 5G professional rugged phones, XP Pro 5G rugged smartphones, and XP3plus 5G rugged flip phones. Beyond handsets, DNA X, Inc. also provides connected solutions, offering both fixed wireless access and mobile hotspot devices. These include the Sonim H100 low- and mid-range mobile hotspots, the Sonim H700, and the advanced Sonim H500-series of 5G mobile hotspots. Complementing its hardware offerings, the company supplies proprietary SonimWare software and a selection of industrial-grade accessories. DNA X, Inc. distributes its products through a diverse network that includes wireless carriers, data device distributors, communications system integrators, and electronics resellers. The company's clientele spans various critical industries, including transportation and logistics, construction, manufacturing, facilities management, energy and utilities, mining, federal government agencies, and public safety organizations.
- CEO
- Michael C. Mulica
- Employees
- 4
- Beta
- 1.80
Explore
Frequently asked questions
What is the intrinsic value of DNA X, Inc. (SONM)?
InvestorsCraft does not currently publish an intrinsic value for SONM. How the IC value is calculated.
Is SONM undervalued?
InvestorsCraft does not publish an undervaluation signal for SONM at this time.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.